Gabelli & Co Investment Advisers’s Myovant Sciences Ltd. MYOV Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82,450	Closed	-$2.22M	–	291
2022 Q4	$2.22M	Buy	+82,450	New	+$2.17M	0.47%	45

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's MYOV Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 82,450 shares — an estimated $2.22M sold.

Gabelli & Co Investment Advisers first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $2.22M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Gabelli & Co Investment Advisers reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 82,450 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.22M.
Gabelli & Co Investment Advisers first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Myovant Sciences Ltd. position peaked at $2.22M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.